Bedrick Todd, Senior Vice President and Chief Accounting Officer at Absci Corp, has reported a transaction involving 22,325 shares of the company's common stock. This transaction, which took place on October 12, 2026, is significant as it reflects Todd's ongoing engagement with the company's equity management. The filing was made on October 14, 2026, and is part of Todd's regular stock management activities.
Absci Corp, based in Vancouver, Washington, is classified under the Standard Industrial Classification for Services-Commercial Physical & Biological Research. The company has undergone several name changes in the past, transitioning from AbSci, LLC to AbSci, Inc., and finally to Absci Corp in 2020. The recent filing indicates that Todd's transaction was not a discretionary trade but rather a withholding of shares to cover tax obligations related to the vesting of restricted stock units.
According to the filing, Todd now owns 199,128 shares following this transaction. The shares were acquired under the Absci Corporation 2021 Employee Stock Purchase Plan, which highlights the company's commitment to employee ownership and engagement. The filing also notes that Todd's recent transaction included shares acquired on March 31, 2026, and September 30, 2026.
Such transactions by executives can influence market perceptions and employee morale within the biotechnology sector. Stakeholders may view Todd's continued investment in Absci as a positive signal of the company's future prospects. The filing does not specify what actions may follow this transaction, leaving some uncertainty regarding future developments.